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Abstract 
 
Background: Congenital heart disease (CHD) entails a broad spectrum of malformations with 
various degrees of severity and prognosis. Consequently, new and specific healthcare needs 
are emerging, requiring responsive healthcare provision. Research on this matter is 
predominantly performed on population-based databases, to inform clinicians, researchers and 
policy-makers on health outcomes and economic burden of CHD. Most databases contain data 
either from administrative sources or from clinical systems. We describe the methodological 
design of the BELgian COngenital Heart Disease Database combining Administrative and 
Clinical data (BELCODAC), to investigate patients with CHD.  
Methods: Data on clinical characteristics from three university hospitals in Belgium (Leuven, 
Ghent and Brussels) were merged with mortality and socio-economic data from the official 
Belgian statistical office (StatBel), and with healthcare use data from the InterMutualistic 
Agency, an overarching national organization that collects data from the seven sickness funds 
for all Belgian citizens. Over 60 variables with multiple entries over time are included in the 
database. 
Results: BELCODAC contains data on 18,510 patients, of which 8,926 patients (48%) have a 
mild, 7,490 (41%) a moderately complex and 2,094 (11%) a complex anatomical heart defect. 
The most prevalent diagnosis is Ventricular Septal Defect in 3,879 patients (21%), followed 
by Atrial Septal Defect in 2,565 patients (14%). 
Conclusions: BELCODAC comprises longitudinal data on patients with CHD in Belgium. 
This will help build evidence-based provision of care to the changing CHD population.  
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Abbreviations: 
ACHD= Adult Congenital Heart Disease 
ASD= Atrial Septal Defect 
AVSD= AtrioVentricular Septal Defect 
BELCODAC= BELgian COngenital Heart Disease Database combining Administrative and 
Clinical data  
CBSS= Crossroads Bank for Social Security  
CC-TGA= Congenitally Corrected Transposition of the Great Arteries 
CHD= Congenital Heart Disease  
CONCOR= CONgenital CORvitia 
DILV= Double Inlet Left Ventricle  
DORV= Double Outlet Right Ventricle 
GDPR= General Data Protection Regulation  
ICD= International Classification of Diseases and Related Health Problems  
IMA= InterMutualistic Agency 
INNR= Identification Number of the National Register  
LVOT= Left Ventricular Outflow Tract 
RN= Random Number 
SLL= Secure Socket Layer 
StatBel= Statistics Belgium 
TGA= Transposition of the Great Arteries, 
TTP= Trusted Third Party  
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VPN= Virtual Private Network  
VSD= Ventricular Septal Defect 
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1. Introduction 
Epidemiology of congenital heart disease (CHD) has changed over the past decades [1-3]. 
The global birth prevalence is estimated to be 9.4 per 1,000 live births [4]. Although a slight 
increase in the birth prevalence was observed worldwide, this prevalence remained relatively 
stable in Western countries [4-6]. Improved treatment options have resulted in a better 
survival and consequently an increase of the prevalence of adult CHD, initially limited to 
mild/moderately complex lesions but more recently also of patients with a complex defect [7]. 
Consequently a new population of older patients (60y and beyond) with mild and moderately 
complex lesions is emerging, with specific healthcare needs [8, 9].  
These changes affect the healthcare system and challenge the design of responsive 
care models. Research focused on current epidemiological characteristics and the impact of 
healthcare provision and organization of care on clinical outcomes and costs at population 
level may help create coordinated healthcare provision for people with CHD that is cost-
effective and accessible, while yielding optimal clinical outcomes. Such research initiatives 
require large multicenter databases containing clinical data and information on healthcare use. 
Population-based CHD-related databases are currently available in several countries [10-19]. 
Most databases contain data from either clinical systems or administrative sources. Though, 
they both have their shortcomings. Where data from clinical systems mostly lack outpatient 
information, data from administrative sources tend to be less reliable in terms of case finding. 
A solution would be the combination of data from clinical and administrative data sources.  
We created a CHD-related database which encompasses demographic, clinical, 
economic and healthcare utilization data from Belgium, which could drive future healthcare 
services and outcome research in CHD. In this paper we describe the design and methodology 
of the BELgian COngenital heart disease Database combining Administrative and Clinical 
data (BELCODAC).  
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2. Material and methods 
2.1. Setting 
Belgium is a European country with a surface area of 30,528 km² and a population of 11.4 
million, yielding a population density of 372 per square kilometer. It consists of three regions: 
Flanders, Wallonia and the Brussels Capital region, with 57.6%, 31.9% and 10.5% of the 
country’s population, respectively [20]. The Belgian population is predominantly white 
Caucasian with a life expectancy at birth of 81.5 years for the whole population in 2018 (83.7 
years for women and 79.2 years for men) [21]. The main causes of death are malignancies in 
men (29.9%) and diseases of the circulatory system in women (29.6%) [22]. The average 
fertility rate is 1.61 child per woman in 2018. There are 3.3 physicians and 5.7 hospital beds 
per 1,000 inhabitants [23, 24]. The healthcare system is characterized by high accessibility 
and compulsory healthcare insurance according to the Bismarck model [25]. In this model, 
employers and employees fund the healthcare insurance through compulsory payroll 
deduction, providing access to sickness funds regardless of pre-existing conditions. Sickness 
funds are public institutions and service costs are governmentally controlled. Costs are 
covered by the health insurance organizations (i.e., sickness funds) and partly by patients (i.e., 
out-of-pocket). Four centers in Belgium perform CHD surgery, of which two are located in 
Flanders (i.e., University Hospitals Leuven and Ghent University Hospital), and two in the 
Brussels Capital region (i.e., Cliniques Universitaires Saint-Luc and Queen Fabiola Children’s 
University Hospital) serving Brussels and Wallonia.  
2.2.Study population 
Patients were eligible for inclusion in BELCODAC when diagnosed with a CHD, defined as 
“a gross structural abnormality of the heart and/or intrathoracic great vessels that is actually 
or potentially of functional significance” [26], and had at least one visit at one of the 
participating hospitals throughout their lifetime. As the merging of the different data sources 
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required the Identification Number of the National Register (INNR) as a unique patient 
identifier, only patients for whom this number was available in the hospital information 
system could be included. Patients with very mild defects including Patent Foramen Ovale 
(PFO) and open ductus of Botalli requiring no intervention, acknowledged spontaneously 
closed Atrial Septal Defect (ASD) or Ventricular Septal Defect (VSD) and isolated mild 
peripheral pulmonary stenosis, were excluded.  
2.3. Data sources 
BELCODAC combines data collected from different sources: the participating hospitals; the 
InterMutualistic Agency (IMA); and StatBel (see supplementary Figure 1). Patients were 
identified through an analysis of medical patient records from three different hospitals in 
Belgium: University Hospitals Leuven, Ghent University Hospital and Cliniques 
Universitaires Saint-Luc.  
2.3.1. University Hospitals Leuven 
University Hospitals Leuven established a digital clinical database in 1992. Data for all 
outpatient visits at the pediatric cardiology center or adult CHD program were prospectively 
collected. Data from 1970 - 1992 was retrospectively obtained from patient records.  
2.3.2. Ghent University Hospital  
Ghent University Hospital prospectively collected data in their clinical collection system since 
2002 for pediatric patients, which was adopted by the adult CHD clinic in 2004. In 2013, the 
adult CHD outpatient clinic started their own system to collect data for patients in follow-up. 
Historical data from adult CHD clinic outpatients were retrospectively collected up to 2008. 
Most variables were coded in the hospital information system.  
2.3.3. Cliniques Universitaires Saint-Luc 
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Cliniques Universitaires Saint-Luc implemented a digital system for patient identification and 
clinical data collection in 1997. All pediatric cardiology outpatient visits are entered into this 
system. 
For all three hospitals, uncertain elements were cross-checked with the patients’ 
medical files. Missing information was obtained through a manual search of these medical 
files. A codebook was used to ensure uniform coding throughout the different hospitals 
providing clinical variables.  
2.3.4. InterMutualistic Agency 
We obtained data on healthcare use and pharmacological data from the seven Belgian health 
insurance organizations. Because health insurance is compulsory, almost every citizen holds a 
membership at one of these seven sickness funds, which manages healthcare payments and 
reimbursements. Around 1% of citizens in Belgium does not hold a membership to a sickness 
fund (e.g. homeless people). This proportion is slightly higher in Brussels Capital Region 
(1.9%) and lowest in Flanders (0.5%) [27]. The InterMutualistic Agency (IMA) is a national 
overarching organization that collects data from these seven organizations for all Belgian 
citizens. IMA started data collection in its current form in 2002 and performs an update every 
six months. Because data during the database start-up (2002-2005) was incomplete, data from 
2006 onwards was included in the final database. Furthermore, because reimbursement can be 
requested from the sickness fund up to 2 years after provision of the health care service and 
data was requested at the end of 2017, we could only get reliable information until 2015. As 
this system is used for reimbursement purposes, the data on healthcare utilization is highly 
accurate. BELCODAC ultimately contains data on healthcare use, available for the period 
from 2006 to 2015.  
2.3.5. StatBel 
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Date and cause of mortality was obtained from StatBel, the Belgian statistical office. StatBel 
obtains physician-reported death certificates for every deceased person in Belgium as of 1991. 
Mortality data were linked to the INNR of Belgian citizens. StatBel additionally provided 
socio-economic and demographic data, which were obtained from the municipalities and the 
censuses of 2001 and 2011 [20].   
2.4. Variables 
Over 60 variables were included in the BELCODAC database (see Table 1). Most variables 
contain multiple entries over time. Several variables, such as date of birth, were validated 
across data sources. Included variables were selected through consensus between physicians 
specialized in CHD care in adult as well as pediatric populations; nurses specialized in CHD 
care; academics experienced in CHD research; and health economists experienced in merging 
administrative and clinical databases.  
BELCODAC comprises data in six main categories: (i) socio-demographic data; (ii) 
medical data; (iii) mortality data; (iv) pharmacological data; (v) healthcare use data; and (vi) 
financial data (see Table 1). Socio-demographic data comprise date of birth, sex, place of 
residence, educational level, marital status, profession, periods of emigration, household type 
and size and social status. Medical data were obtained through the hospitals. This category 
contains information on diagnosis, coded via an adapted version of the CONCOR 
(CONgenital CORvitia) classification [28], level of anatomical complexity based on the 
Bethesda classification [29]. Other relevant existing comorbidities can be derived from IMA 
data through the occurrence of certain healthcare provisions or combinations of healthcare 
use. Mortality data contains information on the date and cause of death. Pharmacological data 
covers prescribed medication use and prescribed therapies with product code and the dosage, 
the date at which it was described and who prescribed the therapy. Healthcare use data 
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contains variables on the type, date and frequency of the patients’ contact with the healthcare 
system. Financial data comprises variables relevant in determining the cost of the healthcare 
use for the patient and the government. Detailed information on the format of these variables 
is presented in supplementary Table 1.   
Additional variables can be generated through the presence (or combination of) certain 
data. For example, information on the presence of infective endocarditis can be generated by 
combining data on duration and type of prescribed antibiotics with hospitalization occurrence.  
PLEASE INSERT TABLE 1 ABOUT HERE 
2.5.Merging of data from different sources 
To merge and combine the information from the five sources, patients’ INNR were sent to a 
Trusted Third Party (TTP) from eHealth, a governmental agency. This TTP provided a 
Random Number (RN) for each patient, enabling the hospitals to send the clinical data on RN 
to a second TTP. After a second coding, performed by the second TTP from the Crossroads 
Bank for Social Security (CBSS), data is merged with data from IMA and StatBel. Ultimately, 
a quadruple coding system (see supplementary Figure 1) ensured a coded database where no 
single party held all of the respective keys enabling identification of individual patients. The 
entire process was supervised by the Data Protection Authority of Belgium. Data are stored on 
a secured server, accessible through a Virtual Private Network (VPN) connection with a 
Secure Socket Layer (SLL) certificate.  
2.6.Ethics and Privacy commission 
Approval of the ethics committee from University Hospitals Leuven, Ghent University 
Hospital and Cliniques Universitaires Saint-Luc was obtained, and the ethics committee of 
Leuven acted as central ethics committee (file numbers S59859 and S59858). The Data 
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Protection Authority reviewed the data collection process rigorously. At this governmental 
level, approval was obtained from three separate committees: the Statistical Supervisory 
Committee; the Sectoral Committee of Social Security and of Health; and the Sectoral 
Committee of the National Register. A small cell risk analysis was performed on the final set 
of requested variables at request of the Sectoral Committee of Social Security and of Health. 
In going through these steps, this project contains the necessary elements to link data of 
administrative institutions and medical facilities in accordance with General Data Protection 
Regulation (GDPR) guidelines. 
3. Baseline data 
We included 18,510 eligible CHD patients through examination of the hospital specific 
clinical databases, contributing 149,048 patient years, 15,808,314 healthcare use records with 
3,305,989 unique contact dates and 48,201 healthcare facility admissions. There were 174,617 
individual visits with a cardiologist. Between 2006 and 2015, we registered 721 childbirths in 
521 women. Furthermore, 719 deaths occurred within the observation period.  
Of these 18,510 included patients, 13,748 (74%) were registered at Leuven University 
Hospitals, 4,274 (23%) at Ghent University Hospital and 488 (3%) patients were obtained at 
Cliniques Universitaires Saint-Luc. Of these patients, 277 had at least one visit in two of the 
participating hospitals. Such patients were assigned to the hospital in which most visits were 
recorded. Figure 1 shows the distribution of the BELCODAC population across birth cohorts, 
stratified per center. Most patients were born between 2000 and 2009 (24%). Our cohort 
contains 8,926 patients (48%) with a mild defect, 7,490 (40%) with a moderately complex 
defect and 2,094 (11%) with a complex defect.  
PLEASE INSERT FIGURE 1 ABOUT HERE 
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The most prevalent diagnosis in this cohort was VSD in 3,879 patients (21%), 
followed by ASD type 2 in 2,565 patients (14%). Within the group of moderately complex 
defects, the most prevalent diagnoses were pulmonary valve abnormality (n=1,739, 9%) and 
coarctation of the aorta (n=1,233, 7%). Within the group of complex defects, Transposition of 
the Great Arteries (TGA) was most prevalent (n=751, 4%). Distribution for the different 
primary diagnoses in the database can be found in Table 3 according to the CONCOR 
classification [28].  
There were 1,576 (9%) patients with a genetic abnormality associated with CHD. The 
most prevalent abnormality was Trisomy 21 (n=564; 3%) followed by Marfan syndrome 
(n=309; 1.7%), Catch 22 syndrome (n=193; 1%), Turner syndrome (n=138; 0.7%), Noonan 
syndrome (n=111; 0.6%) and Williams syndrome (n=66; 0.4%). Another 195 (1.1%) patients 
had an unspecified genetic abnormality. More information on the basic characteristics of the 
BELCODAC population is listed in Table 2. 
PLEASE INSERT TABLE 2 ABOUT HERE 
We registered 22,524 cardiac procedures, obtained from the clinical databases. Thirty-
one% of patients had at least one surgical procedure, 15% had one or more catheter 
interventions and 12% underwent both. The most common procedure was VSD closure 
occurring 1,517 times, followed by ASD closure (n=1,340), trans-catheter ASD closure 
(n=1,178), coarctectomy (n=1,083) and trans-catheter balloon dilation of the pulmonary valve 
(n=1,058). There were 602 pacemaker implantations. 
PLEASE INSERT TABLE 3 ABOUT HERE 
  
4. Discussion 
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We designed and developed BELCODAC, encompassing clinical data and information on 
healthcare utilization and outcomes in patients with CHD. This database aims to inform 
clinicians, researchers and policy-makers regarding the clinical outcomes and economic 
burden of healthcare provision for patients with CHD at all life stages. Additionally, 
BELCODAC exemplifies the inclusion of variables from different sources obtained 
longitudinally.  
Within the field of CHD research, several registries and administrative databases 
already exist [30-32]. Many of the existing databases were originally created for 
reimbursement purposes yet provide a great amount of data on patients across geographic 
regions and centers, enabling epidemiological and outcome research. A recent review 
identified 12 administrative databases used for research on adults with CHD [33]. Although 
all used for CHD research, the only ones that were designed for CHD specifically were the 
Québec CHD database [12] and the Danish Public Registries [11]. Aside from these 
databases, several registries currently exist for CHD [31]. These registries prospectively 
collect data on a group of patients. Examples of such registries are the Dutch CONCOR 
registry [28], the German national register for CHD , the Guangdong Registry of Congenital 
Heart Disease in China [34] and SWEDCON in Sweden [35]. Registries typically miss details 
as they are designed for monitoring performance. Additionally, they may be subject to 
selection bias when they are based on voluntary enrolment or informed consent [33]. 
CHD databases in countries with a Bismarck healthcare model, which do not suffer 
from the bias of socio-economic status, are sparse. The only existing registries that use this 
particular model are based on voluntary enrollment [28, 36].  
4.1.Comparison with other studies 
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Compared to a study examining the overall prevalence of heart defects in the population of 
Quebec, Canada [37], we found lower rates of ASD prevalence (21% in Quebec vs. 15% in 
our cohort) and higher rates of coarctation of the aorta (2% in Quebec vs. 7% in our cohort). 
When comparing to data from Germany [38], data were more in line with ours. Differences 
could be attributed to the average age of the cohort as well as the definition of certain defects. 
Overall, we see very similar results, indicating a sample representative for the population with 
no major differences between our cohort and the overall CHD population outside of Belgium. 
4.2.Strengths of BELCODAC 
BELCODAC contains a large population of patients with CHD suitable for epidemiological 
research. The longitudinal nature of BELCODAC data provides detailed information on 
healthcare use, clinical complications and mortality data throughout all life stages and 
settings. Most existing databases lack out-of-hospital data and data on mortality, providing 
only partial information on healthcare utilization and outcomes [33]. The use of data from 
national health institutes in BELCODAC assures that data are not limited to in-hospital 
contacts and events or to a regional level. Additionally, using data from the hospitals provides 
more detailed and accurate data concerning the medical variables such as diagnosis, 
intervention type and complications. For several variables, data are cross-validated between 
clinical and administrative data, resulting in more reliable data.  
Since patients are included in BELCODAC without preselection, this database is not 
subject to the same level of ascertainment bias as registries that include only a subgroup of 
patients. BELCODAC might therefore provide useful insights for those patients that are often 
missed, such as mild defects or patients who are lost to follow-up. Furthermore, it enables us 
to add socio-economic and demographic data, providing a wide array of variables to 
determine possible confounders. 
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Most of the existing databases use the International Classification of Diseases and 
Related Health Problems (ICD) ninth or tenth revision codes to identify patients [33]. This 
coding may be susceptible to misclassifications when coded by administrative personnel or 
physicians who lack understanding of the ICD-terminology and may lack sufficient detail to 
document complex physiology [33, 39]. Furthermore, since the ICD-coding lacks specific 
CHD subtypes, such as a Norwood procedure, ICD coding is not the ideal classification for 
CHD. We were able to opt for the CONCOR-hierarchy to classify the heart defects, 
specifically designed for CHD research [28].  
The coding list for cardiac interventions was developed by the researchers 
collaborating on BELCODAC. Involving professionals in data collection is important to 
create a valuable database [40]. Whereas other databases often have in-hospital administrative 
sources responsible for the coding of clinical data, ours occurred through collaborations and 
discussions between healthcare professionals, resulting in clinical data representative for the 
patients’ condition as depicted by the physicians in the hospital.  
Although this database is retrospectively designed, it is possible to gather additional 
information in the future on this cohort enabling future analyses when deemed necessary. 
4.3.Limitations of BELCODAC 
Firstly, BELCODAC is not suitable for in-depth analysis of the patients’ physical status, due 
to shortcomings regarding the depth of the data. For instance, physical examinations or 
parameters of echocardiography performed by physicians at outpatient visits, are not included. 
In addition, information on non-reimbursed healthcare use is lacking (e.g. dietician visits and 
some forms of psychotherapy). Over-the-counter (OTC) medication is not included in this 
database. However, OTC medication constitutes a small proportion of medication use in 
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Belgium, mainly comprising simple pain medication, nasal decongestive, vitamins, digestive 
medication and skincare. All types of cardiovascular medication are prescription-based. 
 Secondly, Flemish patients are overrepresented in BELCODAC. We included 
complex CHD patients from only 1 French-speaking hospital. No differences between 
Flemish and Walloon patients in terms of complexity, treatment or clinical outcomes are 
expected, since patients benefit from the same healthcare model and have the same genetic 
background.  
A third limitation is the possibility of selection bias towards more complex defects, 
seeing as all three included hospitals are university hospitals. Although every patient with at 
least one visit in one of the participating hospitals was included, patients with mild CHD 
without the need for referral to an academic hospital are not included in BELCODAC. 
Fourthly, although StatBel reliably captures mortality, physician-reported cause of 
death may be less reliable [41]. Inaccuracies between actual cause of death and data from 
national registries occurs due to incomplete death certificates; diagnostic issues; situations 
where cause of death is ambiguous or cases where death had multiple causes. These 
uncertainties could be present and need to be considered when performing research on cause 
of death using BELCODAC.   
4.4.Governance 
Combining data from clinical and administrative sources as shown in BELCODAC can 
provide meaningful insights for researchers aiming to improve healthcare quality and cost. 
Therefore, the methods used to develop this merged database are pivotal for future 
development of datasets. A first step in this process, was the setup of a collaboration between 
universities, healthcare providers from the hospitals and governmental agencies. A second 
step was the formation of agreements regarding data collection, data storage, ownership, 
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access and analysis. These agreements were made in close collaboration with all involved 
partners, under supervision of the legal offices from the universities and the collaborating 
hospitals and with the national Data Protection Authority. Third, the format and extend of the 
data needed to be agreed upon. For this we developed arguments for the necessity of each 
variable included in the database. This was scrutinized in a small cell risks analysis and 
evaluated by the Data Protection Authority. As a fourth step, the data collection, each partner 
collected the required variables and recoded these to fit the pre-established and agreed upon 
codebook. The data was then encrypted via a triple coding system as shown in Supplementary 
Figure 1. Lastly, we created a publication committee, in which every participating university 
and hospital is represented. This committee supervises data management, data storage and 
authorizes analysis and publication of the data. These steps ultimately resulted in the 
BELCODAC database, where we successfully combined different data sources to form a rich 
database for patients with CHD.  
5. Conclusions 
BELCODAC is designed to contain longitudinal data on patients with CHD in Belgium. 
Linking administrative and clinical data in patients with CHD created a valuable foundation 
for research on clinical outcomes, healthcare use, organization of care and healthcare costs. 
The information obtained through this type of health services research will foster an evidence 
base for the development of healthcare provision adapted to the changing needs of the CHD 
population.  
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Table 1: Overview of variables from different sources in BELCODAC 
 Variables Clinical 
data 
Administrative data 
Source Hospitals StatBel IMA 
Sociodemographic 
data 
Date of birth  x   x 
Gender x   x 
Zip Code x   x 
Education level   x  
Marital status   x  
Profession   x  
Periods of emigration   x  
Household type and size   x  
Social status   x 
Medical data Diagnosis x   
Genetic abnormalities associated with 
Congenital Heart Disease 
x   
Endocarditis x   
Thromboembolic events  x   
Diabetes x    
Other complications and comorbidities 
derived from medical provision and 
medication use 
  x 
Mortality data Date of death x x  
Cause of death  x  
Date last seen alive x   
Pharmacological 
data 
Pharmacological product and dosage     x 
Date of prescription 
treatment/medication/delivery 
    x 
Prescriber     x 
Category of medication   x 
Healthcare data Period of hospitalization     x 
Code Implant      x 
Intervention types x   
Intervention dates x   
Type of healthcare use   x 
Healthcare provider     x 
Institution     x 
Residential care   x 
Number of days of unemployment/sick leave   x 
Financial data Personal monetary contribution to medication 
or healthcare use 
    x 
Health statutes providing financial benefits    x 
Average taxable income 
Amount reimbursed for healthcare use 
  x  
x 
Legend: IMA= InterMutualistic Agency, StatBel= Statistics Belgium 
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Table 2: Basic characteristics of 18,510 patients with congenital heart disease included in 
BELCODAC 
  n (%) 
Sex   
Male 9,193 (49.7) 
Female 9,317 (50.3) 
CHD Complexity   
Mild 8,926 (48.2) 
Moderate 7,490 (40.5) 
Complex 2,094 (11.3) 
Type of intervention*   
Catheter intervention 2,857 (26.3) 
Surgical procedure 5,771 (53.1) 
Both 2,251 (20.7) 
Number of interventions   
none 7,509 (40.6) 
1 6,272 (33.9) 
2 2,098 (11.3) 
3 998 (5.4) 
4 559 (3.0) 
≥5 1,074 (5.8) 
Birth decade   
1920-1929 58 (0.3) 
1930-1939 276 (1.5) 
1940-1949 502 (2.7) 
1950-1959 936 (5.1) 
1960-1969 1,496 (8.1) 
1970-1979 2,021 (10.9) 
1980-1989 2,740 (14.8) 
1990-1999 3,609 (19.5) 
2000-2009 4,434 (24.0) 
2010-2015 2,438 (13.2) 
Genetic abnormalities   
Yes 1,576 (8.5) 
* For 122 patients with at least one intervention, no data were available on the type of intervention  
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Table 3: Primary diagnosis based on the CONCOR classification [28] and the level of 
anatomical complexity [29] of the 18,510 patients in BELCODAC  
Primary diagnosis 
Mild 
n 
Moderate 
n 
Complex 
n 
Total (%) 
Hypoplastic Left Heart Syndrome 
  
141 141 (1%) 
Univentricular physiology 
  
497 497 (3%) 
Tricuspid atresia 
  
55 55 (0.3%) 
Tetralogy of Fallot 
 
1,081 67* 1148 (6%) 
Pulmonary atresia with VSD 
  
91 91 (0.5%) 
Pulmonary atresia without VSD 
  
63 63 (0.3%) 
DORV 
  
177 177 (1%) 
DILV 
  
11 11 (0.1%) 
Truncus arteriosus 
  
97 97 (0.5%) 
TGA 
  
751 751 (4%) 
CC-TGA 
  
144 144 (1%) 
Coarctation of the aorta 
 
1,233 
 
1,233 (7%) 
AVSD 
 
456 
 
456 (2%) 
ASD type 1 
 
208 
 
208 (1%) 
Ebstein malformation 
 
112 
 
112 (1%) 
Pulmonary valve abnormality 
 
1,739 
 
1,739 (9%) 
Aortic valve abnormality 739 560** 
 
1,299 (7%) 
Aortic abnormality 
 
660 
 
660 (4%) 
LVOT obstruction 
 
83 
 
83 (0.5%) 
ASD type 2 2,054 511** 
 
2,565 (14%) 
VSD 3,480 399** 
 
3,879 (21%) 
Mitral valve abnormality 636 132** 
 
768 (4%) 
Pulmonary vein abnormality 
 
307 
 
307 (2%) 
Other 2,009 9 
 
2,018 (11%) 
Idiopathic pulmonary arterial hypertension 8 
  
8 (0.04%) 
Total 8,926 7,490 2,094 18,510 
Legend: ASD= Atrial Septal Defect, AVSD=AtrioVentricular Septal Defect, CC-TGA= Congenitally Corrected 
Transposition of the Great Arteries, DILV= Double Inlet Left Ventricle, DORV= Double Outlet Right Ventricle, 
LVOT= Left Ventricular Outflow Tract, TGA= Transpos ition of the Great Arteries, VSD= Ventricular Septal 
Defect 
* Tetralogy of Fallot in combination with the diagnosis of a complex anatomical defect is considered complex 
** These diagnoses are moderate defects if they occur in the presence of another defect   
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Figure 1: Composition in BELCODAC  
Legend: Composition in BELCODAC of unique patients across the different hospitals for each birth decade and 
level of anatomical complexity [29], with the timeline of data entry at each hospital 
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Supplementary Figure 1: Coding system used to enable merging of data for BELCODAC 
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Legend Supplementary Figure 1 
University hospitals Leuven, University hospital Ghent and Cliniques Universitaires Saint-Luc are making a 
selection of the patients of their clinical databases on to the Identification Number of the National Register 
(INNR). 
1.1 The selection of selected patients from Cliniques Universiaires Saint-Luc will be handed to the 
TTP-eHealth. This list entails only state registration numbers of these selected patients, clinical data 
will not be sent to the TTP eHealth at this time.  
1.2 The selection of selected patients from University hospital Leuven will be handed to the TTP-
eHealth. This list entails only state registration numbers of these selected patients, clinical data will not 
be send to the TTP eHealth at this time. 
1.3 The selection of selected patients from Ghent University hospital will be handed to the TTP-
eHealth. This list entails only state registration numbers of thes e selected patients, clinical data will not 
be send to the TTP eHealth at this time. 
After receiving all lists of the selected state registration numbers (1.1, 1.2 & 1.3) the TTP-eHealth will assign a 
Random Nummer (RN) to every unique INNR. 
2.1. eHealth sends this list of keys with INNR/RN back to the responsible person of Cliniques 
Universitaires Saint Luc. 
2.2. eHealth sends this list of keys with INNR/RN back to the responsible person of University hospitals 
Leuven. 
2.3. eHealth sends this list of keys  with INNR/RN back to the responsible person of Ghent University 
hospital. 
2.4. eHealth sends the merged list of INNR/RN to the security counselor of the National 
Intermutualistic College (NIC) who acts as a Single Point Of Contact (SPOC). 
2.5. eHealth sends the merged list RN/Cproject to the TTP-VI Crossroads Bank for Social Security 
(CBSS).   
 
3.1 The responsible person of Cliniques Universitaires Saint-Luc sends the selected clinical data on RN 
to the TTP VI (CBSS).     
3.2 The responsible person of UZ Leuven sends the selected clinical data on RN to the TTP VI (CBSS).     
3.3 The responsible person of UZ Gent sends the selected clinical data on RN to the TTP VI (CBSS).     
 
4. The security counselor NIC sends the lis t of patients to the TTP VI (CBSS) on C1/RN.   
5. The security counselor NIC sends the list INSZ/RN to the responsible person for Statistics Belgium 
(StatBel). 
 
6. The data from StatBel will be handed to TTP VI (CBSS) on RN. 
7. Using a second coding (C1 → C2) data are selected from the InterMutualistic Agency data 
warehouse (IMA DWH). 
8. Data will be send back to TTP VI (CBSS) on C2. 
9. The TTP-VI (CBSS) replaces the C2 by the Cproject in the IMA data and puts the received data (UZ 
Leuven, UZ Gent, Cliniques Universitaires Saint-Luc & Statistics Belgium) on Cproject. All data will 
be put on Cproject in the IMA DWH. 
10. Small Cell Risk Analysis will be executed by the Sectoral Committee. 
11. The datasets will be made available to the researchers via Cproject. 
 
Abbreviations: CBSS, Crossroads Bank for Social Security; C1, Code number 1; C2, Code number 2; CProject, 
project code; IMA, InterMutualistic Agency; IMA DWH, InterMutualistic Agency data warehouse; INNR, 
Identification Number of the National Register; NIC, National Intermutualistic College; RN, random number; 
TTP, Trusted Third Party, TTP VI, Trusted Third Party Insurance Institutions .   
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Supplementary Figure 2 
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Supplementary Table 1: Overview of all variables and their format in BELCODAC 
Variable Format and values 
  
Hospitals 
Unique patient identifier  
Level of anatomical complexity [29] 1= Mild defect 
2= Defect of moderate complexity 
3= Defect of great complexity 
Primary diagnosis 1= Hypoplastic left heart syndrome 
2= Univentricular physiology 
3= Tricuspid atresia 
4= Tetralogy of Fallot 
5= Pulmonary atresia with ventricular septal defect 
6= Pulmonary atresia without ventricular septal defect 
7= Double outlet right ventricle 
8= Double inlet left ventricle 
9= Truncus arteriosus 
10= Transposition of the great arteries 
11= Congenitally corrected transposition of the great 
arteries 
12= Coarctation of the aorta 
13= Atrioventricular septal defect 
14= Atrial septal defect type 1 
15= Ebstein malformation 
16= Pulmonary valve abnormality 
17= Aortic valve abnormality  
18= Aortic abnormality 
19= Left ventricular outflow tract obstruction 
20= Atrial septal defect type 2 
21= Ventricular septal defect 
22= Mitral valve abnormality 
23= Pulmonary vein abnormality 
24= Other 
Secondary diagnosis See Primary diagnosis 
Tertiary diagnosis See Primary diagnosis 
Date of birth  Always first of the month for privacy reasons 
Sex 0= Woman  
1= Man  
ZIP code  Numerical value representing ZIP-code 
Presence of genetic syndrome 0= Absent 
1= Present  
Type of genetic syndrome 1= Microdeletion 22q11  
3= Marfan 
4= Noonan 
5= Trisomy 21 
6= Turner syndrome 
8= Williams syndrome 
9= Other syndrome 
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Note: 2 and 7= Nonexistent category 
Presence of thromboembolic event (3 
possible entries) 
0= No thromboembolic events 
1= One thromboembolic event 
2= Two or more thromboembolic events 
Date of thromboembolic event  
(3 possible entries) 
Always first of the month for privacy reasons 
 
Type of thromboembolic event  
(3 possible entries) 
1= Stroke 
2= Transient ischemic attack 
3= Arterial thromboembolism 
4= Venous thromboembolism 
5= Septic embolism 
6= Pulmonary embolism 
7= Myocardial infarction - Acute Myocardial Infarct  
8= Thrombosis on implant 
9= Central bleeding 
Presence of infectious endocarditis  0= No infectious endocarditis 
1= One episode of infectious endocarditis 
2= More than one episode of infectious endocarditis 
Date of endocarditis (2 possible entries)  
Occurrence intervention  0= No intervention  
1= Intervention  
Type of intervention  0= Catheter intervention  
1= Surgical procedure 
2= Both  
Date of intervention (10 possible 
entries) 
Always first of the month for privacy reasons 
Type of intervention (10 possible 
entries) 
1= Norwood 
2= Systemic to pulmonary shunt 
3= Banding pulmonary artery 
4= Bidirectional cavopulmonary connection 
5= Total cavopulmonary connection 
6= Catheterization: balloon dilation pulmonary valve 
7= Catheterization: stenting arterial duct 
8= Surgical pulmonary valvulotomy 
9= Systemic to pulmonary shunt 
10= Tetralogy of Fallot repair 
11= Pulmonary atresia & ventricular septal defect 
(Fallot-type) repair 
12= Pulmonary atresia, ventricular septal defect & 
major aortopulmonary collateral arteries repair 
13= Replacement/placement homograft 
14= Catheterization: replacement pulmonary valve 
15= Double outlet right ventricle repair  
16= Truncus repair 
17= Creation of intra-atrial connection (Rashkind or 
surgical opening patent foramen ovale) 
18= Arterial  switch 
19= Rastelli 
20= Senning 
21= Mustard 
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22= Atrial septal defect I repair 
23= Atrioventricular septal defect repair 
24= Atrioventricular septal defect & Tetralogy of 
Fallot repair                  
25= Atrial septal defect closure 
26= Catheterization: atrial septal defect closure  
27= Catheterization: patent foramen ovale closure 
28= Sinus venosus atrial septal defect closure 
29= Ventricular septal defect closure 
30= Catheterization: ventricular septal defect closure 
31= Pulmonary valve procedure(includes subvalvular 
procedures to repair reduced right ventricle outflow) 
32= Catheterization: balloon dilation pulmonary valve 
33= Left ventricle outflow tract procedure  
34= Aortic valve procedure (+ 
implantation/replacement aorta valve homograft) 
35= Catheterization: balloon dilation and/or stenting 
aortic valve 
36= Catheterization: aortic valve replacement 
37= Coarctectomy 
38= Correction interrupted aortic arch 
39= Catheterization: balloon dilation and/or stenting 
coarctatio  
40= Procedures concerning peripheral pulmonary 
artery problems  
41= Composite graft procedure  
42= Valve sparing aortic root replacement  
43= Mitral valve procedure 
44= Mitral valve replacement 
45= Tricuspid valve procedure  
46= Tricuspid valve replacement 
47= Ebstein malformation repair 
48= Pulmonary vein correction 
49= Catheterization: procedure pulmonary veins 
50= Arterial duct closure 
51= Catheterization: arterial duct closure  
52= Aortapulmonary window correction 
53= Vascular ring procedure 
54= Cor triatriatum correction 
55= Repair of congenital coronary abnormalities 
56= Repair of acquired coronary abnormalities 
57= Pacemaker implantation/reimplantation 
58= Implantable cardioverter defibrillator implantation  
59= Catheterization: ablation  
60= Heart transplantation 
61= Assist device 
62= Extracorporeal membrane oxygenation 
Date of last visit to the hospital  Always first of the month for privacy reasons 
Deceased 0= Not deceased 
1= Deceased 
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Date of death  Always first of the month for privacy reasons 
  
Statbel 
Unique patient identifier  
Employment Status 2011 EMP= Employed 
UNE_NW= Unemployed, never worked before 
UNE_W= Unemployed, worked before 
LT_MWA= Person under the national minimum age 
for economic activity 
EDUC= Student 
INC= Pensioners or recipients of capital income 
HOME_IO= Housewife/houseman and other 
UNK= Unknown 
Civil status for each year from 1990 – 
2018  
1= Unmarried 
2= Married 
3= Widow(er) 
4= Divorced 
 Diploma  0= No diploma 
1= Primary education 
2= Lower secondary education, secondary education 
of the 1st or 2nd grade (general secondary education/ 
technical secondary education / art secondary 
education/ vocational secondary education / special 
secondary education) 
3= Higher secondary education 
3A= Higher secondary education, 3rd grade general 
secondary education, higher art secondary education/ 
3rd grade technical secondary education/ art secondary 
education 
3C= Higher professional education, 3rd grade 
vocational secondary education, part-time vocational 
secondary education 
4= Postsecondary non-higher education: 4th grade 
vocational secondary education, 7th year general 
secondary education, technical secondary education, 
art secondary education, vocational secondary 
education; entrepreneur training 
5= Higher education 
5A= Academic bachelor (university college or 
university) – licentiate, engineer, doctor in medicine, 
masters; University college long type/master at a 
university college; Higher education after 
licentiate/masters 
5B= University college education short type, graduate, 
professional bachelors; Higher education after 
graduate/bachelors 
6= Doctoral degree with dissertation 
UNK= unknown 
Cause of Death  World health organization’s international classification 
of diseases version 10  
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Country of emigration (17 possible 
entries) 
B=Belgium 
E=Emigration 
End date of emigration (17 possible 
entries) 
DDMMYY 
Start date of emigration (17 possible 
entries) 
DDMMYY 
Household size for each year from 1990 
-2018 
Number of people living in the household 
Household type for each year from 
1990-2018 
1= Living alone 
2= Married couple without children 
3= Married couple with children 
4= Couple living together without children 
5= Couple living together with children 
6= Single parent 
7= Other type of household 
8= Collective household 
Gross Domestic Income 2001-2017 In euro 
Month of death  
To which person category do you 
belong? 
A= I am a pupil or student 
B= I have a job 
C= I lost or quit my previous job and am looking for a 
new job 
D= I am looking for a job for the first time 
E= I have never exercised a professional activity and I 
am not looking for a job 
F= Retirement 
G= Early retirement pension 
H= I no longer work for family, social, personal, 
health or other reasons 
J= I no longer work because I believe there is no job 
available for me 
K= Other 
L= Not able to respond 
Z= Not filled out 
Teacher lower high school, elementary 
school, or kindergarten 
0= Not obtained 
1= Obtained 
Bachelor non-university 0= Not obtained 
1= Obtained 
Bachelor college or university 0= Not obtained 
1= Obtained 
Master college or university 0= Not obtained 
1= Obtained 
Banaba or Manama 0= Not obtained 
1= Obtained 
PhD 0= Not obtained 
1= Obtained 
Highest education level A= Primary education 
B= Lower high school general secondary education 
C= Lower high school technical secondary education  
D= Lower high school in the arts 
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E= Lower high school vocational secondary education 
F= Higher high school general secondary education 
G= Higher high school technical secondary education  
H= Higher high school in the arts 
J= Higher high school vocational secondary education 
K= Postsecondary non-higher education 
L= Higher education (long or short type, university) 
Z= Not filled out 
Year of death  
  
Intermutualistic Agency  
 
1. Healthcare use data 
Unique patient identifier   
Prescriber category The first 2 numbers of the prescriber number  
10-19= Physicians   
20-29= Pharmacists 
30-39= Dentists 
40= Midwifes 
41-49= Nurses 
50-55= Physiotherapists 
56= Dietitians 
57= Podiatrists 
58= Speech therapists 
59= Orthoptists 
60= Speech therapists 
61= Orthopedists 
62= Bandagists 
63= Providers of implants 
64= Bandagists 
65= Occupational therapists 
66= Opticians 
67= Audiologists 
68= Pharmacists - biologists 
69= Suppliers of self-care materials that are not 
pharmacists 
70= Cognitive behavioral therapist for chronic fatigue 
syndrome, clinical psychologist, clinical remedial 
educationalist 
80-94= Care staff and certified nursing assistant 
95-74= Nursing homes nurses  
98-99= Care staff and certified nursing assistant 
Flag to divide nomenclature code into 
categories 
1= Outpatient 
2= Inpatient 
3= Neutral 
Start date provision DDMMYY 
Nomenclature code URL: 
https://www.riziv.fgov.be/NL/nomenclatuur/Paginas/d
efault.aspx#Tekst_van_de_nomenclatuur  
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Number of cases Number of times a provision was provided; or the 
number of deliveries; or the number of delivered units; 
or the number of times the unit rate was charged on the 
given date or time. 
Number of days  
Amount reimbursed In euro 
Code rightful claimant 1 *1st digit (arrangement): 
0= Undefined states or no right 
1= General arrangement 
4= Self-employed persons arrangement  
Note: 2-3= Nonexistent category 
*2nd digit (category): 
0= Person affiliated with the national register 
1= Active person 
2= Disabled person 
3= Retired person 
4= Widow(er) 
5= Orphan 
6= Disabled (no longer valid) 
7= Member of the monastic communities 
8= International arrangement 
*3rd digit (preferential treatment): 
0= No preferential treatment 
1= Preferential treatment 
Code rightful claimant 2 *for free insurances: 
000= No free insurance 
900= Insurance of 75% without preferential treatment 
901= Free insurance at 100% with preferential 
treatment 
*for obliged insurances 
General arrangement: SS00095=SS00100 
460= Disabled 75% without preferential treatment 
461= Disabled 100% with preferential treatment 
Date of admission  
Date of discharge This is the end date of the admission from a hospital, 
nursing home, retirement home, care facility, 
psychiatric care home, sheltered living or a 
rehabilitation facility. 
Date of last provision  
Related provision A list of provisions for which a related provision needs 
to be filled out can be found on the website of the 
RIZIV (Record type 30, 40 or 50 zone 17 and 18) 
URL: www.riziv.be  
Product number Individual code of a pharmaceutical product 
URL: 
https://ondpanon.riziv.fgov.be/SSPWebApplicationPu
blic/nl/Public/ProductSearch  
Billed nomenclature code URL: 
https://www.riziv.fgov.be/NL/nomenclatuur/Paginas/d
efault.aspx#Tekst_van_de_nomenclatuur 
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Date of prescription DDMMYY 
Personal contribution In euro 
Supplement In euro 
Code implant XXXXYYYZZZZZC 
XXXX= Type of implant 
YYY= Class of the type of implant 
ZZZZZ= Product number of the implant 
C= Check digit 
URL: 
https://www.riziv.fgov.be/nl/professionals/individuele
zorgverleners/verstrekkers-van-
implantaten/Paginas/terugbetaling-implantaten-
lijsten.aspx#Volledige_lijst_van_voor_vergoeding_aa
ngenomen_producten_-
_artikelen_35_en_35bis_van_de_nomenclatuur_(zond
er_de_lijsten_categorie_5_en_categorie_3)_-
_Accessbestanden  
Third party payment scheme 0= No third party payment 
1= Third party payment 
Amount reimbursed on 100% In euro 
Care provider qualification Last 3 numbers of the practitioners prescriber number 
Prescriber qualification Last 3 numbers of the practitioners prescriber number 
Coded variable for SS00075 1= General hospital without university characteristics 
2= General hospital with university characteristics 
3= University hospital 
4= Specialized or psychiatric hospital 
0= Category filled out, but no conversion possible to 
one of the previously listed categories 
.= Category not filled out 
Coded variable for SS00085 1= General hospital without university characteristics 
2= General hospital with university characteristics 
3= University hospital 
4= Specialized or psychiatric hospital 
0= Category filled out, but no conversion possible to 
one of the previously listed categories 
.= Category not filled out 
Type of admission/stay Unknown= Unknown 
ADM= Admission 
ODC-CHIR= Surgical one day admission 
ODC= One day admission 
PSY= Admission to a psychiatric hospital 
POSTCURE= Admission for rehabilitation in 
rehabilitation facility 
Care provider is a general cardiologist 0= Not a general cardiologist 
1= General cardiologist 
Care provider is a pediatric cardiologist 0= Not a pediatric cardiologist 
1= Pediatric cardiologist 
Care provider is a cardiologist 
specialized in congenital heart disease 
0= Not a cardiologist specialized in congenital heart 
disease 
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1= Cardiologist specialized in congenital heart disease 
Prescriber is a general cardiologist 0= Not a general cardiologist 
1= General cardiologist 
Prescriber is a pediatric cardiologist 0= Not a pediatric cardiologist 
1= Pediatric cardiologist 
Prescriber is a cardiologist specialized 
in congenital heart disease 
0= Not a cardiologist specialized in congenital heart 
disease 
1= Cardiologist specialized in congenital heart disease 
  
  
2. Pharmacological data 
Unique patient identifier  
Prescriber category The first 2 numbers of the prescribers prescriber 
number 
Flag to divide nomenclature code into 
categories 
1= Outpatient 
2= Inpatient 
3= Neutral 
Date of deliverance  DDMMYY 
Code drug category Coding: See record type 40 zone 4 of the document: 
“Instructies betreffende de gegevensinzameling van de 
farmaceutische verstrekkingen” 
URL: https://docplayer.nl/42971403-Instructies-
betreffende-de-gegevensinzameling-van-de-
farmaceutische-verstrekkingen.html 
Date of deliverance  DDMMYY 
Code drug category Coding: See record type 40 zone 4 of the document: 
“Instructies betreffende de gegevensinzameling van de 
farmaceutische verstrekkingen” 
URL: https://docplayer.nl/42971403-Instructies-
betreffende-de-gegevensinzameling-van-de-
farmaceutische-verstrekkingen.html 
Quantity Numerical representation of the quantity of the drug 
delivered 
Reimbursement of the health insurance 
1 
Honoraria before new reimbursement method  
Code rightful claimant 1 000= Not according to the rules on 30/06 or 31/12 
*First digit (arrangement):  
0= Undefinable condition or rights 
1= General arrangement 
2= Arrangement for self-employment 
*Second digit (category):  
0= Affiliated with the national register 
1= Actives 
2= Disabled 
3= Retired 
4= Widow(er) 
5= Orphans 
6= Disabled (no longer valid) 
7= Monastic communities 
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8= International arrangements 
*Third digit (preferential treatment or not): 
0= No preferential treatment 
1= Preferential treatment 
Code rightful claimant 2 000= Not according to the rules on 30/06 or 31/12 or 
not entitled to small risks  
900= Insurance at 75% without preferential 
arrangement 
901= Free insurance at 100% with preferential 
arrangement 
460= Disability 75% without preferential arrangement 
461= Disability 100% with preferential arrangement 
Key magistral preparation Unique code that allows every magistral preparation 
(SS00020  = 750234 or 750256 or 750293) to be 
connected to its detail record (SS00020=750315)  
Product number National Codenumber 
URL: 
https://ondpanon.riziv.fgov.be/SSPWebApplicationPub
lic/nl/Public/ProductSearch  
Date of prescription DDMMYY 
Personal contribution In euro 
Reduction of the reimbursement amount In euro 
Reduced reimbursement amount In euro 
Reimbursement of the health insurance 
2 
Honoraria after new reimbursement method  
In euro 
Indication of first delivery 0= Not a first delivery 
1= First delivery 
Supplement In euro 
Prescriber qualification  Last 3 numbers of the practitioners prescriber number 
Coded variable for SS00075 1= General hospital without university characteristics 
2= General hospital with university characteristics 
3= University hospital 
4= Specialized of psychiatric hospital 
0= Category filled out, but no conversion possible to 
one of the previously listed categories 
.= Category not filled out 
Unit in which the quantity is mentioned 1= Milliliter 
2= Milligram 
3= Microgram 
4= Drops 
5= 1.000 units 
6= Square centimeter  
7= Liter 
8= Pieces 
9= Percentage 
10= Gram 
11= 10.000 units 
12= 100.000 units 
13= Microliter 
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Prescriber is a general cardiologist 0= Not a general cardiologist 
1= General cardiologist 
Prescriber is a pediatric cardiologist 0= Not a pediatric cardiologist 
1= Pediatric cardiologist 
Prescriber is a cardiologist specialized 
in congenital heart disease 
0= Not a cardiologist specialized in congenital heart 
disease 
1= Cardiologist specialized in congenital heart disease 
  
3. Population data 
Unique patient identifier  
Year of birth   
Month of birth Equal to zero until the deliverance of the population 
2011vs2 (0 until 2012) 
Year photo Year for which the data accounts for 
Sex 1= Man 
2= Woman 
Titular  0= Dependent person 
1= Titular 
Code rightful claimant 1 000= Not according to the rules on 30/06 or 31/12 
*First digit (arrangement):  
0= Undefinable condition or rights 
1= General arrangement 
2= Arrangement for self-employment 
*Second digit (category):  
0= Affiliated with the national register 
1= Actives 
2= Disabled 
3= Retired 
4= Widow(er) 
5= Orphans 
6= Disabled (no longer valid) 
7= Monastic communities 
8= International arrangements 
*Third digit (preferential treatment or not): 
0= No preferential treatment 
1= Preferential treatment 
Code rightful claimant 2 000= Not according to the rules on 30/06 or 31/12 or 
not entitled to small risks  
900= Insurance at 75% without preferential 
arrangement 
901= Free insurance at 100% with preferential 
arrangement 
460= Disability 75% without preferential arrangement 
461= Disability 100% with preferential arrangement 
Benefit for informal caregiver 0= No 
1= If the beneficiary is in the situation under point g of 
the Royal Decree of 2/6/98 concerning the 
implementation of article 37§16bis of the law of 
14/7/1994 for the reference year 
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Increased disability benefit for informal 
caregiver 
0= No 
1= If the beneficiary is in the situation under point g of 
the Royal Decree of 2/6/98 concerning the 
implementation of article 37 §16bis of the law of 
14/7/94 for the reference year 
Flat-rate benefit for aiding third parties 0= No 
1= If the beneficiary is in the situation under point g of 
the Royal Decree of 2/6/98 concerning the 
implementation of article 37 §16bis of the law of 
14/7/94 for the reference year 
Reimbursement and maximum billing- 
family 
0= No reimbursement  
1= Reimbursement on the base of the ceiling of 450 (or 
350 if entitled to maximum billing for the chronic ill) 
(reimbursed pseudo-codes =781955 or 781756 or 
781874 or 781616) 
2= Reimbursement on the base of the ceiling of 650 (or 
550 if entitled to maximum billing for the chronic ill) 
(reimbursed pseudo-codes =781631 or 781896) 
3= Reimbursement on the base of the ceiling of 1000 
(new photo as of 12.2005) (or 900 if entitled to 
maximum billing for the chronic ill) (reimbursed 
pseudo-codes =781793 or 781675) 
4= Reimbursement on the base of the ceiling of 1800 
(new photo as of 12.2005) (or 1800 if entitled to 
maximum billing for the chronic ill) (reimbursed 
pseudo-codes =781815 or 781690) 
Reimbursement and maximum – 
individual or part of the family  
0= No reimbursement on the base of the individual 
1= Child younger than 19 years (Until maximum 
billing for the chronic ill 2003: -16 years) at 01.01 of 
the reference year – ceiling 650 (or 550 if entitled to 
maximum billing for the chronic ill) (first reimbursed 
pseudo-codes =781933 or 781734) 
2= Child with increased child benefit - ceiling of 450 
(or 350 if entitled to maximum billing for the chronic 
ill) (first reimbursed pseudo-codes =781933 or 
781734) 
3= Reimbursement Social maximum billing in a family 
income-maximum billing on the base of ceiling 450 (or 
350 if entitled to maximum billing for the chronic ill) 
(first reimbursed pseudo-codes =781955 or 781756 and 
PP3001=4) 
The right to guaranteed income 0= No right to guaranteed income 
1= Right to guaranteed income 
Right to disability allowances 0= No right to disability allowances 
1= Right to disability allowances  
Right to assistance from Public Centre 
for Social Welfare 
0= No right to assistance from Public Centre for Social 
Welfare 
1= Right to assistance from Public Centre for Social 
Welfare 
Right to maximum billing for the 0= Indicates no change to maximum billing for the 
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chronic ill chronic ill 
1= Indicates ceiling maximum billing for the chronic 
ill decreased with 100€ since family member 
personally obtained 450€ patient contribution 2 
consecutive years, meaning this member of the family 
personally has “right to maximum billing for the 
chronic ill” 
2= Indicates ceiling maximum billing for the chronic 
ill decreased with 100€ since a member of the family 
to which individual belongs has “right to maximum 
billing for the chronic ill” 
Number of unemployment days as 
indicated on the unemployment forms 
model F of the reference year 
Numerical representation of the number of 
unemployment days 
Number of days of incapacity for work Numerical representation of the number of days of 
incapacity for work 
Number of days of disability Numerical representati n of the number of days of 
disability 
Evaluation of the degree of self-reliance Score on the medical-social scale (0-18) for the 
following items: 
- Level of mobility  
- Capability for preparing and eating food 
- Capability to manage personal hygiene and 
dressing 
- Capability to maintain one’s home and perform 
household chores 
- Capability to live without supervision, being aware 
of danger and able to avoid danger 
- Capability to communicate and social contact 
With 4 answering possibilities: 
- No difficulty 
- Limited difficulties 
- Major difficulties 
- Impossible without help from third parties 
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Highlights 
 
- BELCODAC includes clinical data on healthcare use and outcomes in patients with 
CHD. 
- It is an alliance between universities, hospitals and governmental organizations. 
- BELCODAC comprises longitudinal data on 18,510 patients with CHD in Belgium.  
- It will enable research on outcomes and economic burden of healthcare use in CHD. 
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